Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin.

about

Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin.

Item

http://www.wikidata.org/entity/Q51121337

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@en

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@nl

type

Item

label

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@en

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@nl

prefLabel

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@en

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@nl

P1476

Effects of alloantibodies to h ...... erum levels of thrombomodulin.

@en

P2093

E Lévesque

http://www.w3.org/2001/XMLSchema#string

O Désy

http://www.w3.org/2001/XMLSchema#string

P Vallin

http://www.w3.org/2001/XMLSchema#string

S A De Serres

http://www.w3.org/2001/XMLSchema#string

S Béland

http://www.w3.org/2001/XMLSchema#string

P2860

Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers

TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases.

Diagnosis and management of antibody-mediated rejection: current status and novel approaches.

Effect of antibodies on endothelium.

MHC class II signaling in antigen-presenting cells.

P304

1020-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13661

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28239987

http://www.w3.org/2001/XMLSchema#string